Back to search

Article

Oral Ursodeoxycholic Acid Therapy Failed to Mitigate SARS-CoV-2 Omicron Infection

2024-09-08

Abstract excerpt

<title>Abstract</title> <p>Background Ursodeoxycholic acid (UDCA) was reported to reduce susceptibility to SARS-CoV-2 infection by downregulating farnesoid X receptor (FXR) -ACE2 signaling. However, we found a different story in real-world clinical studies. Methods We attempted to verify whether UDCA can effectively prevent SARS-CoV-2 transmission or have positive therapeutic effects in a real-world clinical st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ab24d3de-2204-5181-b6a6-899a1a4625ef
DOI
10.21203/rs.3.rs-4837114/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oral Ursodeoxycholic Acid Therapy Failed to Mitigate SARS-CoV-2 Omicron InfectionDOI 10.21203/rs.3.rs-4837114/v1
Select a neighboring publication to make it the new centre.